Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IPAB’s Tough Road: Republicans Opt Not To Help Find Members

This article was originally published in The Gray Sheet

Executive Summary

House Speaker Boehner and Senate Majority Leader McConnell “respectfully decline” the president’s request to submit names of individuals to serve on the Medicare Independent Payment Advisory Board.

You may also be interested in...



Health Spending Growth Sees 5.5 Percent Rise After Years Of Recession Lows

National health care spending grew 5.5 percent between 2013 and 2014 after years of more modest increases linked to the recession, CMS actuaries said. Also, DME growth dropped from 4.2 to 2.9 percent last year, but will rise by 5.1 percent by the end of 2015, according to the Medicare agency.

HHS Appointee Burwell Tells Senate Panel IPAB Will ‘Never Be Activated’

HHS Secretary nominee Sylvia Mathews Burwell told Senate HELP Committee members at her May 8 nomination hearing that the Independent Payment Advisory Board required by the Affordable Care Act will likely “never be activated” because the Obama administration has been able to lower health care costs.

Obama Budget Seeks Prior-Authorization Ability For All Medicare Fee-For-Service Items

The administration’s March 4 budget request, repeats past attempts to expand prior-authorization requirements for power wheelchairs and advanced imaging, while also giving CMS the authority to institute prior-authorization for all Medicare fee-for-service items.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032077

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel